Planet Labs holder plans sale of 52K shares

Planet Labs PBC (PL) received a notice that ULYSSES TRUST 02021.1 U/ADTD 02/26/2021 intends to sell common stock under Rule 144.

Rhea-AI Filing Summary

Planet Labs PBC (PL) received a notice that ULYSSES TRUST 02021.1 U/ADTD 02/26/2021 intends to sell common stock under Rule 144. The trust lists 52,240 common shares to be sold through Morgan Stanley Smith Barney LLC. Over the prior three months, the trust sold 89,593 shares for $2,322,223.68 in 10b5-1 transactions.

Key Figures

Shares to be sold under Rule 144: 52,240 shares Estimated value of shares to be sold: $836,884.80 Shares sold in prior 3 months: 89,593 shares +3 more

6 metrics

Shares to be sold under Rule 144 52,240 shares Common stock of Planet Labs PBC listed in the current notice

Estimated value of shares to be sold $836,884.80 Associated with 52,240 Planet Labs PBC common shares in the Rule 144 notice

Shares sold in prior 3 months 89,593 shares 10b5-1 sales of Planet Labs PBC common stock on July 10, 2026

Proceeds from prior 3‑month sales $2,322,223.68 Total consideration for 89,593 shares sold on July 10, 2026

Issuer phone number 4158293313 Contact number for Planet Labs PBC

Form 144 signature date September 17, 2026 Date signed by /s/ Robert Schingler

Key Terms

Rule 144, Restricted Stock Units, 10b5-1

3 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Restricted Stock Units financial

"Common | 09/15/2026 | Restricted Stock Units | Issuer"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

10b5-1 regulatory

"10b5-1 Sales for ULYSSES TRUST 02021.1 U/ADTD 02/26/2021"

A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing mean for Planet Labs PBC (PL)?

The filing states that ULYSSES TRUST 02021.1 U/ADTD 02/26/2021 intends to sell 52,240 common shares of Planet Labs PBC under Rule 144, indicating a planned secondary sale by an existing holder rather than a new issuance by the company.

How many Planet Labs (PL) shares are covered by this Form 144 notice?

The notice covers 52,240 shares of common stock of Planet Labs PBC. These shares are listed as securities to be sold through Morgan Stanley Smith Barney LLC under Rule 144.

Who is selling the PL shares in this Form 144?

The selling holder is ULYSSES TRUST 02021.1 U/ADTD 02/26/2021. The notice identifies this trust as the person for whose account the Planet Labs PBC common stock is to be sold under Rule 144.

What prior Planet Labs (PL) sales did the trust report in the past 3 months?

The trust reported prior 10b5-1 sales of 89,593 common shares of Planet Labs PBC on July 10, 2026 for total proceeds of $2,322,223.68.

Which broker is handling the planned PL share sale under this Form 144?

The planned sale of Planet Labs PBC common stock is listed through Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004.

What type of Planet Labs (PL) securities are involved in this filing?

The filing involves common stock of Planet Labs PBC. The securities to be sold are tied to Restricted Stock Units with a listed date of September 15, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/17/2026 - 04:33 PM Accepted by SEC EDGAR 09/17/2026 - 04:33 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001897636
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	PLANET LABS PBC
SEC File Number	001-40166
Address of Issuer	645 Harrison Street, Floor 4 San Francisco CALIFORNIA 94107
Phone	4158293313
Name of Person for Whose Account the Securities are To Be Sold	ULYSSES TRUST 02021.1 U/ADTD 02/26/2021
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	52240	836884.80	340354193	09/17/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/15/2026	Restricted Stock Units	Issuer			52240	09/15/2026	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for ULYSSES TRUST 02021.1 U/ADTD 02/26/2021 645 Harrison Street, Floor 4 San Francisco CA 94107	Common	07/10/2026	89593	2322223.68

144: Remarks and Signature

Remarks
Date of Notice	09/17/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	04/23/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Robert Schingler
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)